Study schema and key findings. #, R-mega CHOP, R-COMP, R-CHOEP, G-MALL-B-ALL/NHL2000. DA-EPOCH-R, dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab; G-MALL-B-ALL/NHL2000, German Multicenter Adult Acute lymphoblastic leukemia protocol; R-CHOEP, rituximab, cyclophosphamide, doxorubicin, vincristine, etoposide, prednisone; R-COMP, rituximab, cyclophosphamide, vincristine, nonpegylated liposomal doxorubicin, prednisone; R-mega CHOP, rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone; R-VACOP/MACOP-B, rituximab, etoposide, doxorubicin, cyclophosphamide, vincristine, prednisolone, bleomycin/methotrexate, doxorubicin, cyclophosphamide, vincristine, prednisolone, bleomycin.